61 related articles for article (PubMed ID: 1982840)
1. CAPD in diabetics: use of aminoacids.
Renzo S; Beatrice D; Giuseppe I
Adv Perit Dial; 1990; 6():53-5. PubMed ID: 1982840
[TBL] [Abstract][Full Text] [Related]
2. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
3. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?
Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F; Onesti G
Trans Am Soc Artif Intern Organs; 1982; 28():280-6. PubMed ID: 6761936
[No Abstract] [Full Text] [Related]
4. [The effect of dialysis solutions containing amino acids on the nutritional status of patients treated with continuous ambulatory peritoneal dialysis].
Opatrná S; Liska J; Vít L; Hostasová A; Opatrný K
Cas Lek Cesk; 1997 Jun; 136(13):409-12. PubMed ID: 9333515
[TBL] [Abstract][Full Text] [Related]
5. [Biochemical changes with continuous ambulant peritoneal dialysis (CAPD)].
Fuchs C; Armstrong VW; Dorn D; Ebert R; Scheler F
Z Urol Nephrol; 1982 Jun; 75(6):415-27. PubMed ID: 6750973
[TBL] [Abstract][Full Text] [Related]
6. [Continuous ambulatory peritoneal dialysis in diabetic patients].
Stojimrović B; Nesić V
Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
[TBL] [Abstract][Full Text] [Related]
7. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic parameters of CAPD and CCPD in diabetics with terminal renal insufficiency].
Thomae U; Kuhlmann H; Herrmann M; Büchele W
Dtsch Med Wochenschr; 1984 Jun; 109(24):941-4. PubMed ID: 6734446
[TBL] [Abstract][Full Text] [Related]
9. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
Arfeen S; Goodship TH; Kirkwood A; Ward MK
Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
[TBL] [Abstract][Full Text] [Related]
10. Long-term continuous ambulatory peritoneal dialysis in diabetics.
Balaskas EV; Yuan ZY; Gupta A; Meema HE; Blair G; Bargman J; Oreopoulos DG
Clin Nephrol; 1994 Jul; 42(1):54-62. PubMed ID: 7923968
[TBL] [Abstract][Full Text] [Related]
11. Ultrafiltration failure and dialysate glucose in CAPD.
Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
[TBL] [Abstract][Full Text] [Related]
12. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
Li GW; Liu J; Chen L
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
Babazono T; Miyamae M; Tomonaga O; Omori Y
Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
[TBL] [Abstract][Full Text] [Related]
14. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
Douma CE; de Waart DR; Struijk DG; Krediet RT
Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
[TBL] [Abstract][Full Text] [Related]
15. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
17. Hypophosphatemic effect of 1% amino acid dialysis solution.
Arfeen S; Kirkwood A; Goodship TH; Ward MK
Adv Perit Dial; 1989; 5():167-70. PubMed ID: 2577404
[TBL] [Abstract][Full Text] [Related]
18. [Program of continuous ambulatory peritoneal dialysis and renal transplantation in insulin-dependent diabetics in the terminal stage of renal insufficiency].
Mousson C; Tanter Y; Chalopin JM; Rifle G
Nephrologie; 1987; 8(4):205-9. PubMed ID: 3320798
[TBL] [Abstract][Full Text] [Related]
19. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.
Strauss FG; Holmes DL; Dennis RL
Adv Perit Dial; 1995; 11():110-3. PubMed ID: 8534681
[TBL] [Abstract][Full Text] [Related]
20. Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance.
Grzegorzewska AE; Wiecek A; Mariak I; Kokot F
Adv Perit Dial; 2000; 16():7-14. PubMed ID: 11045252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
